PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
About PTC Clinical Trials Careers at PTC
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Names Eric Pauwels Svp & General Manager Commercial Operations, Americas
PTC Therapeutics And University Of Pennsylvania Collaborate On Orphan Disease Research
View all latest news